Prelude Therapeutics reported total assets of $189.36M and total liabilities of $55.63M for the quarter ended Jun 2026, up 64.8% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 61.42M | 35.87M | 55.68M | 54.75M | 56.07M | 34.65M | 22.25M | 30.49M | 19.94M | 29.34M | 28.75M | 31.87M | 15.18M | 16.52M | 44.31M | 29.80M | 58.20M | 38.49M | 84.80M | 155.20M | ||||||||
| Short-term InvestmentsInvestments (Current) | 259.44M | 259.40M | 214.56M | 195.60M | 172.02M | 171.12M | 154.05M | 228.54M | 214.61M | 207.64M | 177.22M | 152.02M | 142.49M | 121.14M | 58.80M | 47.46M | 7.42M | 67.96M | 59.80M | 125.43M | ||||||||
| Cash & Current Investments | 320.87M | 295.28M | 270.23M | 250.35M | 228.09M | 205.77M | 176.30M | 259.03M | 234.55M | 236.98M | 205.97M | 183.89M | 157.67M | 137.66M | 103.12M | 77.26M | 65.62M | 106.45M | 144.60M | 280.63M | ||||||||
| Prepaid Assets | 5.03M | 3.88M | 3.78M | 2.32M | 2.85M | 2.65M | 3.01M | 5.22M | 4.41M | 2.65M | 3.44M | 2.87M | 2.76M | 2.28M | 3.33M | 3.66M | 3.37M | 2.48M | 3.04M | 3.14M | ||||||||
| Current Assets | 325.90M | 295.12M | 269.97M | 248.62M | 226.89M | 204.38M | 175.26M | 260.21M | 234.92M | 235.59M | 205.37M | 182.71M | 156.39M | 135.90M | 102.40M | 76.88M | 58.33M | 105.69M | 84.59M | 154.90M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 3.21M | 3.93M | 4.12M | 4.29M | 5.11M | 4.91M | 5.37M | 6.08M | 6.62M | 7.33M | 7.29M | 7.55M | 7.20M | 6.77M | 6.39M | 5.96M | 5.53M | 5.11M | 4.72M | 4.40M | ||||||||
| Other Non-Current Assets | 4.04M | 4.04M | 4.04M | 4.93M | 5.38M | 12.28M | 9.36M | 12.47M | 4.04M | 4.04M | 4.04M | 4.04M | 4.04M | 4.04M | 4.04M | 3.23M | 3.23M | 3.23M | 3.40M | |||||||||
| Non-Current Assets | 5.32M | 9.98M | 10.70M | 10.43M | 15.43M | 16.12M | 23.06M | 20.40M | 23.59M | 42.08M | 41.74M | 41.58M | 40.83M | 39.62M | 38.86M | 38.04M | 36.42M | 35.62M | 35.05M | 34.47M | ||||||||
| Assets | 331.22M | 305.10M | 280.67M | 259.06M | 242.33M | 220.50M | 198.32M | 280.61M | 258.51M | 277.67M | 247.11M | 224.29M | 197.22M | 175.51M | 141.26M | 114.92M | 94.75M | 141.31M | 119.64M | 189.36M | ||||||||
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payables | 11.06M | 7.84M | 7.39M | 6.27M | 10.25M | 6.78M | 7.08M | 5.58M | 5.17M | 4.58M | 5.31M | 6.17M | 5.92M | 7.73M | 5.83M | 4.96M | 2.53M | 3.98M | 2.07M | 2.03M | ||||||||
| Payables | 11.06M | 7.84M | 7.39M | 6.27M | 10.25M | 6.78M | 7.08M | 5.58M | 5.17M | 4.58M | 5.31M | 6.17M | 5.92M | 7.73M | 5.83M | 4.96M | 2.53M | 3.98M | 2.07M | 2.03M | ||||||||
| Accumulated Expenses | 6.76M | 9.62M | 6.82M | 7.72M | 9.92M | 13.09M | 11.19M | 8.67M | 11.25M | 15.77M | 10.15M | 11.43M | 13.58M | 15.21M | 11.30M | 13.23M | 12.93M | 12.53M | 5.94M | 7.98M | ||||||||
| Other Accumulated Expenses | 0.57M | 0.09M | 0.35M | 0.29M | 0.17M | 0.52M | 0.89M | 0.81M | 0.82M | 0.94M | 0.80M | 0.46M | 0.80M | 0.77M | 0.70M | 0.86M | 0.96M | 0.96M | 0.91M | 0.63M | ||||||||
| Current Leases | 1.84M | 1.74M | 1.86M | 1.82M | 1.39M | 1.83M | 1.39M | 0.94M | 0.47M | 1.48M | 2.19M | 2.23M | 2.37M | 2.49M | 2.60M | 2.71M | 2.73M | 2.74M | 2.76M | 2.78M | ||||||||
| Current Deferred Revenue | 3.00M | 33.73M | 30.95M | 25.25M | ||||||||||||||||||||||||
| Total Current Liabilities | 19.66M | 19.20M | 16.07M | 15.81M | 21.56M | 21.70M | 19.66M | 15.19M | 16.89M | 21.83M | 17.64M | 23.34M | 22.22M | 25.64M | 19.79M | 20.91M | 18.19M | 52.99M | 41.72M | 38.04M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 1.80M | |||||||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||
| Operating Leases | 0.31M | 0.39M | 16.89M | 15.45M | 18.20M | 18.14M | 15.32M | 15.27M | 15.21M | 15.13M | 15.04M | 14.96M | 14.87M | |||||||||||||||
| Other Non-Current Liabilities | 2.40M | 2.40M | 3.36M | 3.36M | 3.36M | 3.36M | 3.36M | 3.34M | 3.28M | 3.21M | 3.15M | 3.09M | 3.03M | 2.97M | 2.90M | 2.84M | 2.78M | 2.72M | ||||||||||
| Total Non-Current Liabilities | 19.20M | 16.46M | 15.81M | 21.56M | 21.70M | 19.66M | 15.19M | 16.89M | 37.24M | 33.09M | 38.80M | 37.64M | 40.97M | 35.05M | 36.11M | 33.32M | 69.84M | 56.68M | 52.91M | |||||||||
| Total Liabilities | 19.98M | 19.20M | 18.86M | 18.21M | 24.92M | 25.06M | 23.02M | 18.55M | 20.25M | 40.58M | 36.37M | 42.02M | 40.79M | 44.06M | 38.08M | 39.08M | 36.22M | 72.68M | 59.46M | 55.63M | ||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||
| Common Equity | 311.24M | 285.90M | 261.81M | 240.84M | 217.41M | 195.44M | 175.30M | 262.06M | 238.26M | 237.09M | 210.73M | 182.28M | 156.43M | 131.46M | 103.18M | 75.84M | 58.53M | 68.64M | 60.18M | 133.73M | ||||||||
| Liabilities and Shareholders Equity | 331.22M | 305.10M | 280.67M | 259.06M | 242.33M | 220.50M | 198.32M | 280.61M | 258.51M | 277.67M | 247.11M | 224.29M | 197.22M | 175.51M | 141.26M | 114.92M | 94.75M | 141.31M | 119.64M | 189.36M | ||||||||
| Retained Earnings | -186.30M | -219.12M | -248.60M | -276.00M | -305.92M | -334.56M | -362.30M | -392.71M | -423.31M | -456.39M | -487.82M | -522.60M | -554.83M | -583.56M | -615.65M | -646.90M | -666.60M | -683.06M | -693.45M | -707.40M | ||||||||
| Treasury Shares |